Skip to main content

The Wistar Institute

|

The Wistar Institute Announces the Appointment of Scott Cooper, Ph.D., Richard G. Phillips, Jr., and Steven V. Abramson to Its Board of Trustees

PHILADELPHIA — (Oct. 13, 2020) — The Wistar Institute is pleased to welcome Scott Cooper, Ph.D., Richard G. Phillips Jr., Esq., and Steven V. Abramson, to its Board of Trustees. The new trustees bring diverse expertise and perspectives to the missio…
Read more
|

A Life at the Intersection of Music, Biotechnology and Business

A conversation with Anne Schoemaker about her vision to sponsor The Wistar-Schoemaker International Postdoctoral Fellowship, a partnership launched in 2019 by Wistar and Leiden University Medical Center (LUMC) in the Netherlands to bring LUMC gradua…
Read more
|

New Mechanism of Cell Survival in Chronic Lymphocytic Leukemia

PHILADELPHIA — (Sept. 30, 2020) — Researchers at The Wistar Institute unraveled a mechanism employed by chronic lymphocytic leukemia (CLL) cells for their survival. According to the study, published online in Cellular & Molecular Immunology, mal…
Read more
|

Women & Science: Developing Immunotherapies for Emerging Pathogens That Threaten Global Health

Wistar’s first Women & Science event of the COVID-19 era took place virtually and, appropriately, featured Dr. Ami Patel, a Wistar scientist that is playing a major role in the work being done at the Institute to develop solutions for the pandem…
Read more
|

Wistar Appoints Ami Patel, Ph.D., as Caspar Wistar Fellow

PHILADELPHIA — (Sept. 14, 2020) — The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease research, and vaccine creation, announces the appointment of Ami Patel, Ph.D., as a Caspar Wistar Fellow in…
Read more
|

Scientists Engineer DNA-based Nanotechnology to Stimulate Potent Antitumor Immune Responses in Preclinical Models

PHILADELPHIA — (Sept. 10, 2020) — Combining their expertise in protein engineering and synthetic DNA technology, scientists at The Wistar Institute successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and…
Read more
|

The BEAT-HIV Martin Delaney Collaboratory Issues Recommendations on Measuring Persistent HIV Reservoirs in Cure-directed Clinical Trials

PHILADELPHIA — (Sept. 7, 2020) — Spearheaded by scientists at The Wistar Institute, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled t…
Read more
|

Scientists Use Knowledge From Traditional Medicine to Discover Drugs to Fight the Pandemic

Dr. Ian Tietjen came to Wistar in 2019 as a research assistant professor in the laboratory of Dr. Luis Montaner. He brings a fascinating approach to HIV and infectious disease research that explores the traditional medicine knowledge of In…
Read more
|

Wistar Science Highlights: New Discoveries on HIV Latency and How Cancer Cells Talk With Their Neighboring Normal Cells

Antiretroviral therapy (ART) has dramatically increased the health and life expectancy of HIV-infected individuals, suppressing virus replication in the host immune cells and stopping disease progression; however, low yet persistent amounts of…
Read more
|

Breast Cancer Cells Use Message-carrying Vesicles to Send Oncogenic Stimuli to Neighboring Normal Cells 

PHILADELPHIA — (Aug. 10, 2020) — According to a study by The Wistar Institute, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells. These messages are packaged into particles…
Read more